Eita Uchida

Hidaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

YAP-TEAD-driven CPA4 promotes NF2-deficient meningioma growth.

YAP-TEAD-driven CPA4 promotes NF2-deficient meningioma growth.

Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026

FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics.

FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics.

Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026

Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models.

Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models.

Journal: PloS one
Published: April 11, 2025

Disruption of ataxia telangiectasia-mutated kinase enhances radiation therapy efficacy in spatially directed diffuse midline glioma models.

Disruption of ataxia telangiectasia-mutated kinase enhances radiation therapy efficacy in spatially directed diffuse midline glioma models.

Journal: The Journal of clinical investigation
Published: January 18, 2024

BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma.

BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma.

Journal: The Journal of clinical investigation
Published: August 17, 2023

Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors.

Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors.

Journal: Brain tumor pathology
Published: October 20, 2021

Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance.

Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance.

Journal: Cancer science
Published: May 16, 2021

Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma.

Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma.

Journal: Brain tumor pathology
Published: April 23, 2021

The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.

The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.

Journal: Cancer science
Published: December 03, 2020

Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation.

Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation.

Journal: Cancers
Published: October 26, 2020

Intracytoplasmic dot-like inclusions as cytopathologically useful findings of ependymoma: Case report of adolescent supratentorial anaplastic ependymoma with clear cell morphology.

Intracytoplasmic dot-like inclusions as cytopathologically useful findings of ependymoma: Case report of adolescent supratentorial anaplastic ependymoma with clear cell morphology.

Journal: Clinical case reports
Published: June 30, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026